The expression of human antimicrobial peptide LL-37 in the human nasal mucosa

Am J Rhinol. 2004 Nov-Dec;18(6):381-5.

Abstract

Background: LL-37, an antimicrobial peptide, has been discovered to be produced by a number of epithelial cells. It is identified as a key element in the innate host defense mechanism. Because little is known about the expression of LL-37 in human sinonasal tract, we conducted this study to investigate the expression of LL-37 in human nasal mucosa.

Methods: We investigated the expression of LL-37 gene by the reverse transcription polymerase chain reaction (RT-PCR) and localization of LL-37 peptide by immunohistochemistry in the inferior turbinate mucosa of 7 normal subjects and the nasal polyps of 12 patients with chronic paranasal sinusitis.

Results: The transcripts of the LL-37 gene were detected in all human nasal tissues analyzed by RT-PCR. There is a significant increase of LL-37 mRNA expression in nasal polyps as compared with the normal nasal mucosa. Using immunohistochemistry, LL-37 peptide was localized in surface epithelial cells and submucosal glands.

Conclusions: Our findings suggest that LL-37 is expressed by nasal mucosa and is upregulated during inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antimicrobial Cationic Peptides / metabolism*
  • Case-Control Studies
  • Cathelicidins
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Nasal Mucosa / metabolism*
  • Nasal Mucosa / pathology
  • Nasal Polyps / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Turbinates / metabolism*
  • Up-Regulation

Substances

  • Antimicrobial Cationic Peptides
  • Cathelicidins